Regina Vollmert, Production Assistant
MEDICE The family company stands for reliable medicines. I've been giving my best for this since 1994.
Regina Vollmert, Production Assistant
You are here: Home / Service from MEDICE. / From the company / DORITHRICIN® strongly supported by new clinical evidence published in the peer-reviewed International Journal of Clinical Practice

DORITHRICIN® strongly supported by new clinical evidence published in the peer-reviewed International Journal of Clinical Practice

DORITHRICIN® strongly supported by new clinical evidence published in the peer-reviewed International Journal of Clinical Practice
When Dec 02, 2018
from 07:10 PM to 07:10 PM
Add event to calendar vCal
iCal

DORITHRICIN® strongly supported by new clinical evidence published in the peer-reviewed International Journal of Clinical Practice (Palm et al IJCL Nov. 2018): in a placebo-controlled, multi-center, randomized clinical trial in 321 patients with acute pharyngitis complete remission 72 hours after initial dosing (1°endpoint) was achieved in 64% more patients treated with DORITHRICIN compared to placebo. Within 5 minutes a significant reduction in pain throat and difficulty swallowing was observed. Less cases of bacterial superinfection were noted.